Antibodies with modified isoelectric points
Abstract:
The invention relates generally to compositions and methods for altering the isoelectric point of an antibody, and in some cases, resulting in improved plasma pharmacokinetics, e.g. increased serum half-life in vivo.
Public/Granted literature
Information query
Patent Agency Ranking
0/0